ADMA vs LI · P/E 22, rev $426.5M vs P/E 24, rev $16.06B
ADMA Biologics Inc (ADMA) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
Latest reported ADMA revenue for 2024-12-31 was $426.5M. Net income was $197.7M. Revenue was up 65.2% from 2023-12-31 to 2024-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the ADMA and LI stock pages for the full models.
Not investment advice.